Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

US FDA's Software Pre-Cert Program: Is The Authority On The Books?

July 31, 2018, Medtech Insight

Wade Ackerman is quoted in Medtech Insight regarding the FDA’s software pre-certification program and what that means for device and digital health firms interested in getting new products to the market. Mr. Ackerman says, "The agency has been transparent in that it is considering various legal mechanisms available to the agency to establish the program – recently saying it plans to use FDA's current statutory and regulatory authorities. Many stakeholders we're working with are interested to see how FDA will outline its legal approach to the program." Ackerman adds, “I think ultimately Congress may want a say on FDA's approach, as we’ve seen in many other contexts from accelerated drug approval to the digital-health provision" in the 21st Century Cures Act.”

Share this article: